Skip to main content
Log in

Trimetazidine as indirect antioxidant

  • Biophysics and Biochemistry
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

One-month therapy with trimetazidine sharply decreased the content of free radical oxidation products, lipid peroxides and malonic dialdehyde, in atherogenic low-density lipoproteins in patients with coronary heart disease. Activity of glutathione peroxidase utilizing lipid peroxides in the plasma markedly increased during trimetazidine therapy. The data suggest that trimetazidine not directly interacting with free radicals attenuates the adverse effects of intensive free radical oxidation in coronary heart disease. This effect is mediated via activation of antioxidant enzymes, which diminishes negative consequences of ischemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. O. M. Eliseev,Ter. Arkh., No. 8, 57–63 (1996).

    Google Scholar 

  2. V. Z. Lankin and S. M. Gurevich,Biological Antioxidants [in Russian], Moscow (1975), pp. 146–150.

  3. V. Z. Lankin and S. M. Gurevich,Dokl. Akal. Nauk SSSR,226, No. 3, 392–395 (1976).

    Google Scholar 

  4. V. Z. Lankin, A. K. Tikhaze, and Yu. N. Belenkov,Kardiologiya, No. 6, 58–71 (2000).

    Google Scholar 

  5. A. K. Tikhaze, V. Z. Lankin, S. V. Kolycheva,et al., Byull. Eksp. Biol. Med.,126, No. 11, 551–554 (1998).

    CAS  Google Scholar 

  6. A. K. Tikhaze, V. Z. Lankin, V. P. Mikhin,et al., Ter. Arkh., No. 9, 35–41 (1997).

    Google Scholar 

  7. C. Beauchamp and J. Fridovich,Anal. Biochem.,44, 276–278 (1971).

    Article  PubMed  CAS  Google Scholar 

  8. E. Fantini, L. Demaison, E. Sentex,et al., J. Mol. Cell. Cardiol.,26, 949–958 (1994).

    Article  PubMed  CAS  Google Scholar 

  9. L. Flohe,Free Radic. Biol.,5, 223–254 (1982).

    CAS  Google Scholar 

  10. C. Harpey, P. Clauser, C. Labrid,et al., Cardiovasc. Drug. Res.,6, 292–312 (1989).

    Article  Google Scholar 

  11. J. Nourooz-Zadeh, J. Tajaddini-Sarmadi, and S. P. Wolf,Anal. Biochem.,220, 403–409 (1994).

    Article  PubMed  CAS  Google Scholar 

  12. D. E. Paglia and W. N. Valentine,J. Lab. Clin. Med.,70, 158–169 (1967).

    PubMed  CAS  Google Scholar 

  13. V. V. Tertov, V. V. Kaplun, S. N. Dvoryantsev, and A. N. Orekhov,Biochem. Biophys. Res. Commun.,214, 608–613 (1995).

    Article  PubMed  CAS  Google Scholar 

  14. F. M. Williams, K. Tanda, M. Kus, and T. J. William,J. Mol. Cell. Cardiol.,24, Suppl. 1, 90 (1992).

    Article  Google Scholar 

  15. Y. Yamamoto, Y. Nagata, E. Niki,et al., Biochem. Biophys. Res. Commun.,193, 133–138 (1993).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 130, No. 10, pp. 395–398, October, 2000

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tikhaze, A.K., Lankin, V.Z., Zharova, E.A. et al. Trimetazidine as indirect antioxidant. Bull Exp Biol Med 130, 951–953 (2000). https://doi.org/10.1007/BF02682035

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02682035

Key words

Navigation